Literature DB >> 27863280

Smoking status and its relationship to demographic and clinical characteristics in first episode psychosis.

Michael Grossman1, Christopher R Bowie2, Martin Lepage3, Ashok K Malla4, Ridha Joober5, Srividya N Iyer6.   

Abstract

Elevated rates of cigarette smoking are observed prior to the onset of psychosis and remain stable early in the illness. Cannabis use frequently co-occurs with cigarette smoking and is independently associated with distinct clinical outcomes. However, past research has not controlled for cannabis use in cigarette smokers with first episode psychosis (FEP), limiting conclusions on the unique relationship of cigarette smoking to the demographic and clinical profiles of these patients. The present study therefore aimed to: (1) Determine the prevalence and patterns of cigarette smoking and its co-use with cannabis in FEP, and (2) Examine the demographic, clinical, cognitive, and functional characteristics associated with cigarette smoking status, after adjusting for frequency of cannabis use. Patients entering specialized treatment for FEP (N = 140) were divided into groups according to their current smoking status: 66 non-smokers (0 cigarettes/day), 47 light/moderate smokers (1-19 cigarettes/day; M = 9.81, SD = 3.93), and 27 heavy smokers (≥20 cigarettes/day; M = 26.39, SD = 6.31). The prevalence of cigarette smoking was 53% and smoking status was highly associated with frequency of cannabis use. After adjusting for cannabis use, significant between-group differences emerged. Heavy smokers were older at program entry and had a later age of onset of psychosis than light/moderate and non-smokers. Non-smokers had more education, better neurocognitive performance, and higher levels of functioning than light/moderate and heavy smokers. Prospective, longitudinal studies are needed to better understand the clinical significance of tobacco use and factors that contribute to the initiation and continuation of smoking behaviours in FEP.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cannabis; Cognition; First episode psychosis; Smoking; Symptoms; Tobacco

Mesh:

Year:  2016        PMID: 27863280     DOI: 10.1016/j.jpsychires.2016.10.022

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  6 in total

1.  Cannabis use and metabolic syndrome among clients with first episode psychosis.

Authors:  Erik Stiles; Karl C Alcover; Bryan Stiles; Oladunni Oluwoye; Michael G McDonell
Journal:  Early Interv Psychiatry       Date:  2020-09-02       Impact factor: 2.732

2.  Motivations to quit smoking and challenges faced during cessation among individuals with first episode psychosis in Singapore.

Authors:  Vathsala Sagayadevan; Edimansyah Abdin; Shazana Shahwan; Pratika Satghare; Fiona Devi; Laxman Cetty; Jagan R Sendren; Swapna K Verma; Siow Ann Chong; Mythily Subramaniam
Journal:  Early Interv Psychiatry       Date:  2019-03-28       Impact factor: 2.732

3.  Smoking Is Related to Reduced Motivation, But Not Global Cognition, in the First Two Years of Treatment for First Episode Psychosis.

Authors:  Brandon Schermitzler; Kathleen Miley; Sophia Vinogradov; Ian S Ramsay
Journal:  J Clin Med       Date:  2021-04-11       Impact factor: 4.241

4.  Impact of smoking Behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study.

Authors:  Heleen S van der Heijden; Frederike Schirmbeck; Matthew J Kempton; Mark van der Gaag; Kelly Allott; Barnaby Nelson; Stephan Ruhrmann; Lieuwe de Haan; Jentien M Vermeulen
Journal:  Eur Psychiatry       Date:  2021-09-21       Impact factor: 5.361

5.  Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis.

Authors:  Priyanthi B Gjerde; Synne W Steen; Trude S J Vedal; Nils Eiel Steen; Elina J Reponen; Ole A Andreassen; Vidar M Steen; Ingrid Melle
Journal:  Front Psychiatry       Date:  2022-03-29       Impact factor: 4.157

6.  Metabolic syndrome following a first episode of psychosis: results of a 1-year longitudinal study conducted in metropolitan Lisbon, Portugal.

Authors:  Ricardo Coentre; Pedro Levy; Carlos Góis; Maria Luísa Figueira
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.